Company Filing History:
Years Active: 2008
Title: Darrell Yamashiro: Innovator in Tumor Regression Methods
Introduction
Darrell Yamashiro is a notable inventor based in Westwood, NJ (US). He has made significant contributions to the field of oncology through his innovative methods for tumor regression. His work focuses on utilizing vascular endothelial growth factor (VEGF) inhibitors to combat cancer effectively.
Latest Patents
Yamashiro holds a patent for a method of tumor regression with VEGF inhibitors. This patent describes methods of regressing or inhibiting a tumor in a subject by administering an agent capable of blocking, inhibiting, or ameliorating VEGF-mediated activity. The method results in a reduction of tumor size and inhibition of tumor metastases, making it particularly useful for patients suffering from bulky, metastatic cancers. He has 1 patent to his name.
Career Highlights
Darrell Yamashiro is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to develop and refine his innovative approaches to cancer treatment. His work has the potential to significantly impact the lives of patients battling severe forms of cancer.
Collaborations
Yamashiro collaborates with esteemed colleagues such as Jessica Kandel and Jocelyn Holash, contributing to a dynamic research environment focused on advancing cancer therapies.
Conclusion
Darrell Yamashiro's contributions to the field of oncology through his patented methods for tumor regression highlight his commitment to improving cancer treatment. His innovative work at Regeneron Pharmaceuticals, Inc. continues to pave the way for advancements in cancer care.